These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2978872)

  • 1. [Neuropsychological deterioration in Huntington chorea].
    Junqué C; Peiró A; Grau-Veciana JM; Escartín A; Barraquer-Bordas L
    Neurologia; 1987; 2(3):109-13. PubMed ID: 2978872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A neuropsychological study of Huntington's disease in families in Antioquia, Colombia].
    Arango-Lasprilla JC; Iglesias-Dorado J; Moreno S; Lopera F
    Rev Neurol; 2003 Jul 1-15; 37(1):7-13. PubMed ID: 12861500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropsychological deterioration in Huntington's disease].
    Deus-Yela J; Pujol J; Espert R
    Rev Neurol; 1997 Aug; 25(144):1257-68. PubMed ID: 9340161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High insulinlike growth factor I is associated with cognitive decline in Huntington disease.
    Saleh N; Moutereau S; Azulay JP; Verny C; Simonin C; Tranchant C; El Hawajri N; Bachoud-Lévi AC; Maison P;
    Neurology; 2010 Jul; 75(1):57-63. PubMed ID: 20603485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity.
    Nehl C; Paulsen JS;
    J Nerv Ment Dis; 2004 Jan; 192(1):72-4. PubMed ID: 14718780
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of object-naming in Huntington chorea].
    Podoll K; Caspary P; Lange HW; Noth J
    Z Exp Angew Psychol; 1988; 35(2):242-58. PubMed ID: 2970156
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of donepezil on motor and cognitive function in Huntington disease.
    Cubo E; Shannon KM; Tracy D; Jaglin JA; Bernard BA; Wuu J; Leurgans SE
    Neurology; 2006 Oct; 67(7):1268-71. PubMed ID: 17030764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech and language delay are early manifestations of juvenile-onset Huntington disease.
    Rosenberger PB
    Neurology; 2007 Apr; 68(16):1325; author reply 1325. PubMed ID: 17438232
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive changes in Huntington's disease.
    Paulsen JS; Conybeare RA
    Adv Neurol; 2005; 96():209-25. PubMed ID: 16385769
    [No Abstract]   [Full Text] [Related]  

  • 11. Two years' follow-up of rivastigmine treatment in Huntington disease.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased frontal choline and neuropsychological performance in preclinical Huntington disease.
    Gómez-Ansón B; Alegret M; Muñoz E; Sainz A; Monte GC; Tolosa E
    Neurology; 2007 Mar; 68(12):906-10. PubMed ID: 17372125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive disorders at the onset of Huntington disease].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):226-7. PubMed ID: 15704279
    [No Abstract]   [Full Text] [Related]  

  • 14. [Executive dysfunction in Huntington's disease].
    Redondo Vergé L; Brown RG; Chacón J
    Rev Neurol; 2001 May 16-31; 32(10):923-9. PubMed ID: 11424047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Before chorea: pre-Huntington mild cognitive impairment.
    Lichter DG; Hershey LA
    Neurology; 2010 Aug; 75(6):490-1. PubMed ID: 20610834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychometric study in Huntington disease].
    Pasquier F; Cabaret M; Petit H
    Encephale; 1993; 19(4):303-11. PubMed ID: 8275917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia and cognitive changes in Huntington's disease.
    Morris M
    Adv Neurol; 1995; 65():187-200. PubMed ID: 7872140
    [No Abstract]   [Full Text] [Related]  

  • 19. [Huntington disease: clinical and genetic study in a Spanish population].
    Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
    Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical onset of symptoms in Huntington disease: severe cognitive decline preceding chorea or other motor manifestations.
    Cooper DB; Ales G; Lange C; Clement P
    Cogn Behav Neurol; 2006 Dec; 19(4):222-4. PubMed ID: 17159620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.